Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
Mpox
Type of publications
NITAG documentation (21)
SAGE documentation (9)
Systematic reviews (SYSVAC) (25)
Regions
Americas (7)
Europe (11)
Western Pacific (3)
Diseases
Mpox (55)
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
Moderate (1)
Low (6)
Critically low (5)
Not applicable (13)
55 results found
2022
∙
CAVEI
CAVEI recommendation on vaccination against monkeypox in Chile
2022
∙
NACI
NACI Rapid Response: Updated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks
2022
∙
Conseil Supérieur des Maladies Infectieuses
CSMI recommendation on dosage and route of administration Jynneos/Imvanex monkeypox vaccine.
2022
∙
Conseil Supérieur des Maladies Infectieuses
CSMI Recommendation on Monkeypox – Update July 25, 2022
2022
∙
CoNaIn
Vaccine for prevention of monkeypox
2022
∙
CoNaIn
CoNaIn 3rd August 2022 meeting minutes
2022
∙
ATAGI
ATAGI clinical guidance on vaccination against Monkeypox
2022
∙
Conseil Supérieur de la Santé (CSS)
Belgium Vaccination strategy against Monkeypox (revision, August 2022)
2022
∙
NIAC
Recommendations for the use of Monkeypox Modified Vaccinia Ankara Vaccines, Imvanex or Jynneos, by the intradermal route
2022
∙
NACI, Public Health Agency of Canada
NACI Rapid Response - Interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register